V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009768 | 190007032 | 0 | 40.5 | Neo-adjuvant (N) | 2021-08-01 | 2021-08-01 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 101135474 |
| 190009770 | 190007033 | 1.76 | 54 | Palliative (P) | 2017-12-08 | 2017-12-12 | METHOTREXATE | 02 | N | METHOTREXATE | 101800305 |
| 190009779 | 190007034 | 0 | 25.7 | null | 2020-03-23 | 2021-09-07 | DACTINOMYCIN + CYCLO + VINCRISTINE | 02 | N | NOT MATCHED | 100310566 |
| 190009780 | 190007035 | 1.79 | 74.7 | null | 2019-08-18 | 2020-02-21 | Avelumab | 02 | N | TRIAL | 100020687 |
| 190009784 | 190007036 | 1.81 | 82 | Neo-adjuvant (N) | 2016-08-17 | 2016-09-14 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100891391 |
| 190009801 | 190007037 | 0 | 51.3 | Neo-adjuvant (N) | 2022-03-08 | 2022-03-17 | EW EuroEwing 2012 Arm A VIDE | 02 | Y | CISPLATIN + CYTARABINE | 101205250 |
| 190009815 | 190007038 | 0 | 43.4 | Curative (C) | 2019-09-08 | 2020-05-17 | Docetaxel + Gemcitabine (prior RT) | 02 | null | DOCETAXEL + GEMCITABINE | 101573241 |
| 190009824 | 190007039 | 1.61 | 65.3 | Curative (C) | 2018-05-24 | 2018-06-13 | METHOTREXATE | 02 | null | METHOTREXATE | 101041721 |
| 190009840 | 190007040 | 0 | 62 | Neo-adjuvant (N) | 2018-08-22 | 2018-08-22 | OST Euramos 1 Closed Trial - M | Y | N | OST M | 100295606 |
| 190009842 | 190007041 | 1.93 | 53.3 | Neo-adjuvant (N) | 2017-10-05 | 2017-10-09 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100070652 |
| 190009843 | 190007042 | 1.75 | 101 | null | 2017-08-06 | 2017-08-06 | Doxorubicin + Methotrexate | 02 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101154844 |
| 190009857 | 190007043 | 1.58 | 48.1 | Curative (C) | 2016-11-15 | 2016-11-23 | Dox + HD Mtx (post PAM) | 02 | N | CISPLATIN | 100491230 |
| 190009865 | 190007044 | 1.6 | 96.65 | Curative (C) | 2021-05-18 | 2021-06-25 | Docetaxel+Gemcitabine (no prior RT) | null | null | DOCETAXEL + GEMCITABINE | 100326896 |
| 190009878 | 190007045 | 0 | 42.8 | Neo-adjuvant (N) | 2018-12-13 | 2019-05-16 | Cisplatin + Fluorouracil + RT 5day | 02 | N | METHOTREXATE HIGH DOSE | 100482626 |
| 190009881 | 190007046 | 1.81 | 92.3 | Curative (C) | 2019-11-29 | 2019-12-21 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | EURAMOS TRIAL | 101302257 |
| 190009882 | 190007047 | 1.63 | 11.2 | Curative (C) | 2018-10-05 | 2018-10-20 | EURAMOS TRIAL | 02 | N | CAV | 101714439 |
| 190009884 | 190007048 | 0 | 70.9 | Palliative (P) | 2019-02-12 | 2019-02-18 | DOCETAXEL + GEMCITABINE | 01 | Y | DOCETAXEL + GEMCITABINE | 101798406 |
| 190009897 | 190007049 | 1.62 | 80.9 | null | 2019-06-05 | 2019-11-16 | EW EuroEwing 2012 Arm A VAI | 02 | null | DINUTUXIMAB BETA | 101513878 |
| 190009905 | 190007050 | 1.84 | 0 | Curative (C) | 2019-09-02 | 2019-09-02 | EW EuroEwing 2012 Arm A VAI | 01 | N | CISPLATIN + CYTARABINE | 100935290 |
| 190009910 | 190007051 | 0 | 62 | 03 | 2014-12-14 | 2016-05-22 | Rituximab | 02 | N | OST MIFAMURTIDE | 101791109 |
| 190009914 | 190007052 | 0 | 31.4 | null | 2018-06-28 | 2018-09-10 | EURAMOS TRIAL | 01 | N | DOXORUBICIN + METHOTREXATE | 101292391 |
| 190009917 | 190007053 | 1.73 | 74 | Palliative (P) | 2021-10-11 | 2021-10-20 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100316004 |
| 190009931 | 190007054 | 0 | 29 | null | 2019-11-14 | 2020-07-25 | Irinotecan + Modified De Gramont | Y | N | OST IE | 100621537 |
| 190009944 | 190007055 | 1.53 | 67 | Curative (C) | 2016-06-06 | 2016-09-24 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 101284814 |
| 190009950 | 190007056 | 0 | 0 | Curative (C) | 2020-02-19 | 2020-02-27 | ECX | 02 | N | CARBOPLATIN + ETOPOSIDE | 100607227 |
| 190009952 | 190007057 | 1.61 | 93.45 | Palliative (P) | 2016-06-05 | 2016-10-30 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | null | VAI | 100639670 |
| 190009977 | 190007058 | 0 | 42.7 | Palliative (P) | 2019-10-19 | 2019-12-06 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 101725784 |
| 190009987 | 190007059 | 0 | 36.5 | 02 | 2018-03-04 | 2018-03-04 | EW EuroEwing 2012 Arm B IE | null | null | EW EUROEWING 2012 ARM B IE | 100962902 |
| 190010002 | 190007061 | 1.65 | 70.2 | Curative (C) | 2020-02-08 | 2020-03-04 | Methotrexate Intermed dose (1g/m2) | 02 | null | METHOTREXATE | 100064157 |
| 190010003 | 190007062 | 1.59 | 47.2 | null | 2017-03-30 | 2017-10-28 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | Y | EURAMOS TRIAL | 101650109 |
| 190010011 | 190007063 | 0 | 60.8 | null | 2020-02-10 | 2020-02-10 | EW EuroEwing 2012 Arm B VC | 02 | null | EW EUROEWING 2012 ARM B VC | 100983073 |
| 190010014 | 190007064 | 0 | 23 | Adjuvant (A) | 2019-10-27 | 2019-11-17 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | EURAMOS TRIAL | 101366220 |
| 190010020 | 190007065 | 0 | 50.3 | Palliative (P) | 2017-11-03 | 2019-02-18 | CARBOPLATIN + RT | 02 | N | GEMCITABINE | 100707734 |
| 190010035 | 190007066 | 0 | 63.6 | 03 | 2020-08-23 | 2020-09-12 | Methotrexate High Dose (3g/m2) | 01 | null | METHOTREXATE | 101667228 |
| 190010044 | 190007067 | 0 | 40.9 | Curative (C) | 2022-03-01 | 2022-03-21 | OST Euramos 1 Closed Trial - IE | 02 | null | IRINOTECAN + TEMOZOLOMIDE | 101484428 |
| 190010045 | 190007068 | 1.9 | null | Palliative (P) | 2019-11-13 | 2019-12-16 | MAP + MIFAMURTIDE | 02 | null | STS RHABDO RMS 2005 2ND TOPO CYCLO | 100182411 |
| 190010063 | 190007069 | 1.56 | 97.05 | Palliative (P) | 2017-04-25 | 2017-06-26 | Ifosfamide | 02 | null | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 101523165 |
| 190010079 | 190007070 | 1.67 | 67.2 | Curative (C) | 2019-01-17 | 2019-03-01 | ETOPOSIDE + IFOSFAMIDE + MESNA | 01 | N | ETOPOSIDE + IFOSFAMIDE | 100830105 |
| 190010085 | 190007071 | 1.66 | 78.4 | Palliative (P) | 2015-01-02 | 2016-12-06 | EW EuroEwing 2012 Arm B VC | null | null | EW EUROEWING 2012 ARM B VC | 100022744 |
| 190010086 | 190007072 | 0 | 48 | null | 2021-03-17 | 2021-03-24 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100813051 |
| 190010091 | 190007073 | 1.52 | 76.2 | Palliative (P) | 2020-09-09 | 2020-09-25 | Methotrexate Intermed dose (1g/m2) | 02 | N | METHOTREXATE | 101727589 |
| 190010093 | 190007074 | 1.55 | 87.9 | Palliative (P) | 2021-09-20 | 2021-09-22 | EW EuroEwing 2012 Arm A/B Zol Acid | 02 | null | DOXORUBICIN + METHOTREXATE | 101125124 |
| 190010098 | 190007075 | 1.77 | 62.6 | Palliative (P) | 2019-12-13 | 2020-05-26 | OST Euramos 1 Closed Trial - A | 02 | null | OST A | 101428675 |
| 190010109 | 190007076 | 1.68 | 89.1 | Palliative (P) | 2016-05-06 | 2017-11-25 | BEP 3 day | N | N | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 100844569 |
| 190010113 | 190007077 | 1.8 | 80.7 | Curative (C) | 2021-11-02 | 2022-05-30 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 02 | N | NOT MATCHED | 100094259 |
| 190010117 | 190007078 | 1.74 | 101 | Neo-adjuvant (N) | 2019-02-06 | 2019-07-31 | PACLITAXEL | 02 | N | TRIAL | 100494715 |
| 190010122 | 190007079 | 1.8 | 73.3 | Adjuvant (A) | 2019-03-31 | 2019-04-02 | METHOTREXATE | 01 | null | METHOTREXATE | 100562215 |
| 190010123 | 190007080 | null | 67 | Palliative (P) | null | 2017-09-29 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100042074 |
| 190010126 | 190007081 | 1.88 | 53 | Palliative (P) | 2020-08-06 | 2020-08-07 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 100810176 |
| 190010128 | 190007082 | 1.73 | 72 | null | 2019-07-02 | 2019-12-10 | ETOPOSIDE + IFOSFAMIDE | 02 | null | ETOPOSIDE + IFOSFAMIDE | 101335572 |